Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities
Advances in molecular medicine have led to identification of worthy cellular and molecular
targets located in extracellular and intracellular compartments. Effectiveness of cancer …
targets located in extracellular and intracellular compartments. Effectiveness of cancer …
Prostate cancer research: the next generation; report from the 2019 Coffey‐Holden prostate cancer academy meeting
Abstract Introduction The 2019 Coffey‐Holden Prostate Cancer Academy (CHPCA)
Meeting,“Prostate Cancer Research: The Next Generation,” was held 20 to 23 June, 2019, in …
Meeting,“Prostate Cancer Research: The Next Generation,” was held 20 to 23 June, 2019, in …
[HTML][HTML] CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis
S Liu, Z Liu, A Shang, J Xun, Z Lv, S Zhou, C Liu… - Scientific Reports, 2023 - nature.com
CD44 plays a key role in the communication of CSCs with the microenvironment and the
regulation of stem cell properties. UALCAN was used to analyze the expression of CD44 in …
regulation of stem cell properties. UALCAN was used to analyze the expression of CD44 in …
STAT3 inhibition combined with CpG immunostimulation activates antitumor immunity to eradicate genetically distinct castration-resistant prostate cancers
Purpose: Prostate cancers show remarkable resistance to emerging immunotherapies,
partly due to tolerogenic STAT3 signaling in tumor-associated myeloid cells. Here, we …
partly due to tolerogenic STAT3 signaling in tumor-associated myeloid cells. Here, we …
Tumor cell heterogeneity and resistance; report from the 2018 Coffey‐Holden Prostate Cancer Academy Meeting
AK Miyahira, RB Den, MI Carlo, R De Leeuw… - The …, 2019 - Wiley Online Library
Introduction The 2018 Coffey‐Holden Prostate Cancer Academy (CHPCA) Meeting,“Tumor
Cell Heterogeneity and Resistance,” was held in Los Angeles, California from June 21 to 24 …
Cell Heterogeneity and Resistance,” was held in Los Angeles, California from June 21 to 24 …
Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting
AK Miyahira, SC Kamran, T Jamaspishvili… - The …, 2024 - Wiley Online Library
Abstract Introduction The 2023 Coffey‐Holden Prostate Cancer Academy (CHPCA) Meeting,
themed “Disrupting Prostate Cancer Research: Challenge Accepted,” was convened at the …
themed “Disrupting Prostate Cancer Research: Challenge Accepted,” was convened at the …
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey− Holden prostate cancer academy meeting
AK Miyahira, JE Hawley, R Adelaiye‐Ogala… - The …, 2023 - Wiley Online Library
Abstract Introduction The 2022 Coffey− Holden Prostate Cancer Academy (CHPCA)
Meeting,“Exploring New Frontiers in Prostate Cancer Research,” was held from June 23 to …
Meeting,“Exploring New Frontiers in Prostate Cancer Research,” was held from June 23 to …
Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey‐Holden Prostate Cancer Academy Meeting
AK Miyahira, JM Lang, RB Den, IP Garraway… - The …, 2016 - Wiley Online Library
Background The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed:“
Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La …
Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La …
Prostate cancer research in the 21st century; report from the 2021 Coffey‐Holden prostate cancer academy meeting
Abstract Introduction The 2021 Coffey‐Holden Prostate Cancer Academy (CHPCA)
Meeting,“Prostate Cancer Research in the 21st Century,” was held virtually, from June 24 …
Meeting,“Prostate Cancer Research in the 21st Century,” was held virtually, from June 24 …
[HTML][HTML] The relationship between obesity, prostate tumor infiltrating lymphocytes and macrophages, and biochemical failure
C Zeigler-Johnson, KH Morales, P Lal, M Feldman - PLoS One, 2016 - journals.plos.org
Background Obesity reflects a chronic inflammatory environment that may contribute to
prostate cancer progression and poor treatment outcomes. However, it is not clear which …
prostate cancer progression and poor treatment outcomes. However, it is not clear which …